Author:
Niederau C.,Heintges T.,Hensel F.,Petry W.,Niederau Ch.,Häussinger D.
Publisher
Springer Berlin Heidelberg
Reference42 articles.
1. Hess G, Weber C, Rossol S, Voth R, Drees N, Meyer zum Büschenfeld KH (1988) Behandlung der Hepatitis B Surface Antigen (HBsAg)-positiven chronischen Hepatitis mit rekombinantem alpha-A-Interferon. Ergebnisse einer Phase Il-Studie. Z Gastroenterol 26: 380–387
2. Mayet WJ, Hess G, Gerken G, Rossol S, Voth S, Manns M, Meyer zum Büschenfelde KH (1989) Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10: 24–28
3. Niederau C, Heintges T, Niederau M, Stremmel W, Strohmeyer G (1992) Prospective randomized controlled trial of sequential treatment with corticoids and alfa-interferon versus treatment with interferon alone in patients with chronic active hepatitis B. Eur J Med 1: 396–402
4. Perillo RP, Schiff ER, Davis GL et al (1990) A randomized controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 323: 295–301
5. Carreno V, Castillo I, Molina J, Porres C, Bartolome J (1992) Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol 15: 102–106